• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症手术中生存机会的Kaplan-Meier计算法的益处与局限性

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.

作者信息

Bollschweiler Elfriede

机构信息

Department of Visceral and Vascular Surgery, University of Cologne, Joseph Stelzmann Strasse 9, 50931 Cologne, Germany.

出版信息

Langenbecks Arch Surg. 2003 Sep;388(4):239-44. doi: 10.1007/s00423-003-0410-6. Epub 2003 Aug 14.

DOI:10.1007/s00423-003-0410-6
PMID:12920602
Abstract

BACKGROUND AND AIM

Especially in malign diseases, the therapeutic decision depends on the prognosis for the individual patient. A prognosis is a prediction of the future course of disease following its onset. Graphical representation of such statistical results-such as the well-known Kaplan-Meier curve-is often used to assist readers of a paper in the interpretation. However, mistakes and distortions frequently arise in the display and interpretation of survival plots. This review aims to highlight such pitfalls and provide recommendations for future practice.

METHODS

Special topics are discussed: the criteria for the presentation of the survival curve, the problem of missing values, estimation of the prognosis in the presence of competing risks, comparison of treatment effects and analysis of survival by tumour-response category.

摘要

背景与目的

特别是在恶性疾病中,治疗决策取决于个体患者的预后。预后是指疾病发病后对其未来病程的预测。此类统计结果的图形表示,如著名的卡普兰 - 迈耶曲线,常被用于辅助论文读者进行解读。然而,在生存曲线的展示和解读中经常出现错误和扭曲。本综述旨在突出此类陷阱,并为未来实践提供建议。

方法

讨论了以下专题:生存曲线呈现的标准、缺失值问题、存在竞争风险时的预后估计、治疗效果比较以及按肿瘤反应类别进行的生存分析。

相似文献

1
Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.癌症手术中生存机会的Kaplan-Meier计算法的益处与局限性
Langenbecks Arch Surg. 2003 Sep;388(4):239-44. doi: 10.1007/s00423-003-0410-6. Epub 2003 Aug 14.
2
Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.根治性胃切除术后胃腺癌患者转移淋巴结比率的预后意义
Chin Med J (Engl). 2014;127(10):1874-8.
3
Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.无论检查的淋巴结数量多少,淋巴结比率都是可切除(R0)胃癌患者的独立预后因素。
Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.
4
Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.483例早期胃癌患者的手术结果:预后、术后发病率和死亡率以及残胃癌
Hepatogastroenterology. 2004 Jan-Feb;51(55):82-5.
5
Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.转移性淋巴结比率与转移性淋巴结数量作为胃癌预后因素的比较。
Eur J Surg Oncol. 2012 Jun;38(6):497-502. doi: 10.1016/j.ejso.2012.01.012. Epub 2012 Mar 23.
6
Prognosis and surgical treatment of gastric cancer invading adjacent organs.侵犯相邻器官的胃癌的预后及外科治疗
ANZ J Surg. 2010 Jul-Aug;80(7-8):510-4. doi: 10.1111/j.1445-2197.2010.05376.x.
7
Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.胃腺癌中检查到的阴性淋巴结数量不足的预后。
Eur J Surg Oncol. 2014 Mar;40(3):358-65. doi: 10.1016/j.ejso.2013.08.027. Epub 2013 Sep 8.
8
Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.荷兰胃癌试验中淋巴结清扫的质量控制。
Br J Surg. 2015 Oct;102(11):1388-93. doi: 10.1002/bjs.9891. Epub 2015 Aug 27.
9
Re-study of gastric cancer: analysis of outcome.胃癌的再研究:结局分析
World J Surg. 2002 Apr;26(4):428-33. doi: 10.1007/s00268-001-0243-9. Epub 2002 Feb 4.
10
[Impact of splenectomy and/or distal pancreatectomy in the prognosis of the proximal gastric cancer].[脾切除术和/或远端胰腺切除术对近端胃癌预后的影响]
Rev Gastroenterol Peru. 2012 Jan-Mar;32(1):32-43.

引用本文的文献

1
Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis.腋窝淋巴结清扫术与伴有前哨淋巴结转移的男性浸润性乳腺癌患者的生存改善相关。
Ann Surg Oncol. 2023 Sep;30(9):5610-5618. doi: 10.1245/s10434-023-13475-7. Epub 2023 May 19.
2
Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrospective study.微创与开放根治性顺行模块化胰脾切除术(RAMPS)治疗胰腺导管腺癌的比较:一项单中心回顾性研究
Surg Endosc. 2021 Jul;35(7):3763-3773. doi: 10.1007/s00464-020-07938-1. Epub 2020 Oct 8.
3

本文引用的文献

1
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies].
Chirurg. 2003 Feb;74(2):139-44. doi: 10.1007/s00104-002-0557-7.
2
Survival curve estimation with partial non-random exposure information.
Stat Med. 2002 Sep 30;21(18):2671-83. doi: 10.1002/sim.1214.
3
Parametric modeling for survival with competing risks and masked failure causes.具有竞争风险和隐性失败原因的生存参数建模
Lifetime Data Anal. 2002 Jun;8(2):177-203. doi: 10.1023/a:1014891707936.
4
Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.
用于改进参数化和动态寿命分析的癌症生存数据表示
Healthcare (Basel). 2019 Oct 28;7(4):123. doi: 10.3390/healthcare7040123.
4
Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.将专家意见与临床试验数据相结合以推断长期生存:以 CAR-T 疗法治疗复发或难治性急性淋巴细胞白血病的儿童和青年为例的研究。
BMC Med Res Methodol. 2019 Sep 2;19(1):182. doi: 10.1186/s12874-019-0823-8.
5
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.定义肝内胆管癌切除术后的长期生存者。
J Gastrointest Surg. 2017 Nov;21(11):1888-1897. doi: 10.1007/s11605-017-3550-7. Epub 2017 Aug 24.
6
An Introduction to Survival Statistics: Kaplan-Meier Analysis.生存统计学导论:Kaplan-Meier分析
J Adv Pract Oncol. 2016 Jan-Feb;7(1):91-100. doi: 10.6004/jadpro.2016.7.1.8. Epub 2016 Jan 1.
7
Mortality in patients with multiple sclerosis.多发性硬化症患者的死亡率。
Neurology. 2013 Jul 9;81(2):184-92. doi: 10.1212/WNL.0b013e31829a3388.
8
Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.新辅助放化疗治疗食管腺癌:ERCC1 基因多态性预测反应和预后。
J Gastrointest Surg. 2012 Jan;16(1):26-34; discussion 34. doi: 10.1007/s11605-011-1700-x. Epub 2011 Sep 29.
9
Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany.在两个中心:波兰与德国,人口统计学和手术实践对胃癌患者的预后相关性。
Gastric Cancer. 2011 Aug;14(3):234-41. doi: 10.1007/s10120-011-0036-2. Epub 2011 Mar 26.
10
SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.SOX2 和巢蛋白在人黑色素瘤中的表达:免疫组化和实验研究。
Exp Dermatol. 2011 Apr;20(4):339-45. doi: 10.1111/j.1600-0625.2011.01247.x.
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.临床试验中事件发生时间结局的生存曲线:良好实践与陷阱
Lancet. 2002 May 11;359(9318):1686-9. doi: 10.1016/S0140-6736(02)08594-X.
5
Quantification of the completeness of follow-up.随访完整性的量化。
Lancet. 2002 Apr 13;359(9314):1309-10. doi: 10.1016/s0140-6736(02)08272-7.
6
Biased methods for estimating local and distant failure rates in breast carcinoma and a "commonsense" approach.用于估计乳腺癌局部和远处复发率的有偏倚方法及一种“常识性”方法。
Cancer. 2001 Oct 15;92(8):2220-7. doi: 10.1002/1097-0142(20011015)92:8<2220::aid-cncr1566>3.0.co;2-v.
7
Extended lymph-node dissection for gastric cancer.胃癌扩大淋巴结清扫术
N Engl J Med. 1999 Mar 25;340(12):908-14. doi: 10.1056/NEJM199903253401202.
8
Missing cause of death information in the analysis of survival data.生存数据分析中缺失的死亡原因信息。
Stat Med. 1996 Oct 30;15(20):2191-201. doi: 10.1002/(SICI)1097-0258(19961030)15:20<2191::AID-SIM358>3.0.CO;2-D.
9
Review of survival analyses published in cancer journals.对发表在癌症期刊上的生存分析的综述。
Br J Cancer. 1995 Aug;72(2):511-8. doi: 10.1038/bjc.1995.364.
10
Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials.
Control Clin Trials. 1983 Mar;4(1):43-52. doi: 10.1016/s0197-2456(83)80011-7.